12 Parallel Symposium 5: ADME/PK Considerations for Next Generation Therapeutics: ADCs, Antibodies, Oligonucleotides, and Liposomes

Targeted Drug Delivery and ADME of Antibody-Drug Conjugates
Stephen C. Alley, Seattle Genetics, Inc.
See more of: Speaker Abstracts